AHMEDABAD, India and NEW YORK, Nov. 26, 2025 /PRNewswire/ -- Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, today announced that it ...

Fears about potentially deadly crystallization in herpes drug vials have spurred Zydus Cadila to yank four lots from the U.S. market. Zydus Pharmaceuticals, the U.S. generics unit of Zydus Cadila ...

Sentynl Therapeutics, a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, have announced that the U.S.

India’s Zydus Lifesciences is in the FDA’s crosshairs once again, this time for a trio of unnamed violations at an injectables facility. Following an FDA inspection that wrapped up this week, Zydus, ...

Five healthcare stocks are in focus as pharma launches, regulatory approvals, acquisitions and new hospital projects drive ...